1.
Oral Contrast-enhanced Helical CT Cholangiography and Its Clinical Application;
口服对比剂螺旋CT胆管成像与临床初步应用
2.
Ferric ammonium citrate solution versus Gd-DTPA dilution as oral contrast agent for MRCP image
2种口服对比剂在MRCP成像中的临床应用价值
3.
Value of Magnesium Sulfate as an Oral Contrast Medium for MRI Inspection of Small Intestine Diseases;
硫酸镁作为口服对比剂在小肠疾病MRI检查中的价值
4.
Mn(Ⅱ)-Pectin as Oral Contrast Agent for Upper Abdominal MR Imaging: Experimental Study;
上腹部MRI检查应用口服对比剂果胶锰的实验研究
5.
Clinical Value of Oral SPIO as a Negative Contrast Agent in MPCP: Preliminary Study;
口服SPIO对比剂在MRCP中的应用研究
6.
Clinical Application and Image Quality Improvement of Magnetic Resonance Cholangiopancreatography Using Different Oral Contrast Agents;
口服不同对比剂对磁共振胰胆管成像图像质量改进及临床应用研究
7.
International Contrast and Countermeasure AboutChina Service Product Export;
我国服务出口的国际比较及对策选择
8.
Renal Anemia Treated with Vein and Orally Taking Iron
静脉与口服铁剂对肾性贫血的临床观察
9.
Medicine in powder form held in suspension, ie to be taken by drinking
药粉悬浮剂（口服用）
10.
The doctor prescribed an oral dose of medicine.
医生开了一剂口服药。
11.
Contrasted Study on JinShuiLiuJunJian Capsule and Its Decoction;
金水六君煎胶囊及其口服液的对比研究
12.
Objective: To observe the relative bioavailability of clarithromycin dry suspension( RDS).
目的观察口服克拉霉素干混悬剂的相对生物利用度。
13.
Effect of Low Dose Mifepristone on Ovarian Function and Endometrial Development;
口服低剂量米非司酮对卵巢功能及子宫内膜发育的影响
14.
FDA’s Risk Management on Listed Oral Sodium Phosphate Products
刍议美国FDA对口服磷酸钠制剂上市后安全风险的监管
15.
Influence of administering food on pharmacokinetics of telmisartan tablet in healthy subjects
进食对健康受试者口服替米沙坦片剂药动学的影响
16.
Analysis of the clinical pharmacokinetics of oral preparations of telmisartan
对国内替米沙坦口服制剂临床药动学试验结果的分析
17.
Relative bioequivalence of tilmicosin(powder or liquid) oral formulations in chickens
口服不同剂型替米考星在鸡体内相对生物等效性研究
18.
The Effect of Oral Lipid Emulsion on Blood Lipids and Antioxidation in Hyperlipidemic Rats;
脂肪乳剂口服制剂对实验性高脂血症大鼠血脂水平及抗氧化能力的影响